AI Scribes Lag Clinicians on Note Quality - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

  • By

  • Kerri Miller

  • April 17, 2026

  • 6 min

Share

Clinical Scorecard: AI Scribes Lag Clinicians on Note Quality

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingSimulated outpatient clinical environment

Key Highlights

  • Study limitations noted regarding real-world applicability.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients receiving care in primary care settings.

          AI scribes may improve efficiency but require careful oversight to ensure quality.

          Clinical Best Practices

          • Address clinician burnout to improve documentation quality in real-world settings.

          Related Resources & Content

          Original Source(s)

          AI Scribes Lag Clinicians on Note Quality

          • by Kerri Miller

          • April 17, 2026

          Related Content

          PRP May Offer the Strongest Hair Transplant Evidence

          Structured review highlights stronger evidence for platelet-rich plasma than for exosome-based and other emerging regenerative therapies while underscoring the need for standardized transplantation-specific research.

          FDA Expands Test for Gastric and Esophageal Cancers

          According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

          GRAPPA, EULAR Criteria May Identify Complex PsA

          Application of newly proposed GRAPPA and EULAR criteria in a longitudinal cohort identified progressively smaller groups of patients with early psoriatic arthritis who experienced persistently worse patient-reported outcomes.